| Stock | Price | 52 Week Range | Marketcap | EPS | Dividend Yield | Chart (24H) | Sector | Employees | Last Updated |
|---|---|---|---|---|---|---|---|---|---|
| $52.57 | 385.31B | 3.72 | 2.16% | Financial Services | 213,000 | 4 hours ago | |||
 Pfizer, Inc. PFE | $24.76 | 140.77B | 1.90 | 6.97% | Healthcare | 81,000 | 4 hours ago | ||
| $152.49 | 356.90B | 6.53 | 2.78% | Consumer Defensive | 108,000 | 4 hours ago | |||
| $69.71 | 300.88B | 3.01 | 2.92% | Consumer Defensive | 69,700 | 4 hours ago | |||
| $25.14 | 178.72B | 3.13 | 4.51% | Communication Services | 139,970 | 4 hours ago | |||
| $522.73 | 244.89B | 19.62 | 1.16% | Industrials | 112,900 | 4 hours ago | |||
| $115.39 | 494.45B | 7.00 | 3.41% | Energy | 61,000 | 4 hours ago | |||
| $386.68 | 384.90B | 14.77 | 2.39% | Consumer Cyclical | 470,000 | 4 hours ago | |||
| $190.40 | 463.72B | 10.24 | 2.70% | Healthcare | 138,100 | 4 hours ago | |||
| $305.79 | 219.06B | 11.62 | 2.42% | Consumer Cyclical | 150,000 | 4 hours ago |
Last week was anything but calm for the **Dow Jones Industrial Average** (DJI). Despite a shorter trading week due to the long holiday weekend, the market was brimming with drama, volatility, and a plethora of investment opportunities. The Dow Jones opened strong on Tuesday, climbing 106 points, but by Wednesday it slid back down 106 points. Thursday seemed promising until a late-afternoon downturn led to a modest 21-point gain. Friday, however, saw the Dow flat for most of the day before a significant 208-point drop in the last two hours, culminating in a weekly loss of 187 points or 1.22%. As other significant indexes like the **S&P 500** and **Nasdaq** followed suit with their own declines of 1.16% and 0.09%, respectively, the market fluctuations created intriguing prospects for savvy investors.
The Big Winner of the Week: Bank of America (BAC)
Editor’s Note: Analysis and insight for this article were originally sourced from our friends at The Motley Fool
Against the backdrop of declines, Bank of America (BAC) emerged as the week’s big winner, showing a 3.17% rise. The driving force? Rising interest rates. While historically low rates had previously kept the spread between what **BAC** borrows at and lends at relatively narrow, recent rate hikes are widening this spread, enabling **BAC** to rake in higher profits on low-risk banking transactions. Despite the lingering Countrywide issues, **BAC** is proving its resilience and capacity for profit growth.
Analyst Ratings and Forecasts for Bank of America (BAC):
| Category | Value |
| Consensus Rating | Overweight |
| Average Price Target | $44.19 |
| Potential Gain | 14.1% |
| Number of Ratings | 24 |
Summary of Analysts’ Outlook:
Analysts have a positive outlook on Bank of America, with a consensus rating of Overweight. The average price target of $44.19 suggests a potential gain of 14.1% from the current price. Most analysts believe that the bank’s strong financial position, solid loan growth, and improving interest rate environment will drive earnings growth and share price appreciation.
Sources:
- Bloomberg: Bank of America Corp (BAC:US) – Bloomberg Terminal
- Refinitiv (formerly Thomson Reuters Financial & Risk): Bank of America Corp (BAC) – Analyst Estimates
- Yahoo Finance: Bank of America Corp (BAC) – Analyst Estimates
- TipRanks: Bank of America Corp (BAC) – Analyst Ratings and Price Targets
Pfizer (PFE): Can a 14.1% Potential Gain Outshine a Bad Week?
Pfizer took a notable hit, falling by 6.23%. This substantial decline can be traced to a trio of setbacks that hit on Friday. First, the healthcare sector in general had a rough day, with industry bellwether UnitedHealth losing 3.14%. Second, Pfizer was downgraded by a SunTrust analyst who set a conservative 12-month price target at $27 per share. Lastly, rising interest rates exerted pressure on high-yield blue-chip stocks, as more investors turned to the relative safety of Treasury bonds, which now offer returns comparable to Pfizer’s 3.3% dividend yield.
Analyst Ratings and Forecasts for Pfizer (PFE):
| Category | Rating/Value |
| Consensus Rating | Overweight (4.33/5) |
| Average Price Target | $44.45 |
| Potential Gain | 14.1% |
| Number of Ratings | 19 |
Summary of Analysts’ Outlook:
Analysts have a generally positive outlook on Pfizer, with a consensus rating of Overweight. The average price target of $44.45 suggests a potential gain of 14.1% from the current price. Many analysts believe that Pfizer’s diversified product portfolio, strong pipeline, and cost-saving initiatives will drive growth and improve profitability.
Sources:
- Yahoo Finance: Pfizer Inc. (PFE) Analyst Ratings
- Refinitiv: Pfizer Inc. (PFE) Analyst Estimates
- TipRanks: Pfizer Inc. (PFE) Analyst Ratings and Price Targets
- Bloomberg: Pfizer Inc. (PFE) Analyst Ratings and Estimates
Procter & Gamble (PG): CEO Change Sparks Turmoil
Procter & Gamble recorded the week’s largest decline, dropping 6.25%. This drop is notable as it eclipses the 5.31% fall witnessed last April post the lower-than-expected first-quarter revenue report. Investors reacted to the announcement of former CEO A.G. Laffley’s return, likely leading to an overreaction and profit-taking following early May gains. The Wall Street Journal reported Laffley is already implementing significant managerial changes, restructuring P&G into four operating divisions. While this move aims to enhance operational efficiency, it may also increase corporate costs and internal competition.
Analyst Ratings and Forecasts for Procter & Gamble (PG):
| Category | Value |
| Consensus Rating | Overweight |
| Average Price Target | $154.14 |
| Potential Gain | 12.1% |
| Number of Ratings | 24 |
Summary of Analysts’ Outlook:
Analysts have a generally positive outlook on Procter & Gamble, with a consensus “Overweight” rating. The average price target of $154.14 implies a potential gain of 12.1% from the current price. This suggests that analysts believe the stock has room for growth and is a good investment opportunity.
Sources:
- Yahoo Finance: PG Analyst Estimates
- TipRanks: PG Analyst Ratings
- CNN Business: PG Analyst Estimates
Coca-Cola (KO): Global and Domestic Issues Cause This Dip
Coca-Cola saw a 5.32% drop, driven by slower-than-expected GDP growth in China and other international market challenges. The Venezuelan bottling plant strike, which the company forecasts will reduce revenue by at least 15%, further compounded these difficulties. Domestically, ongoing efforts to combat obesity also weigh on Coke’s performance. However, Coca-Cola’s strong global brand and diversification strategies present reasons for optimism.
Analyst Ratings and Forecasts for Coca-Cola (KO):
| Metric | Value |
| Consensus Rating | Hold |
| Average Price Target | $61.44 |
| Potential Gain | 10.3% |
| Number of Ratings | 22 |
Summary of Analysts’ Outlook:
Analysts have a mixed outlook on Coca-Cola Company, with a consensus rating of Hold. The average price target of $61.44 implies a potential gain of 10.3% from the current price. While some analysts see the company’s diversified portfolio and strong brand recognition as positives, others are concerned about the impact of changing consumer preferences and increasing competition in the beverage industry.
Sources:
- Yahoo Finance: KO Analyst Estimates
- TipRanks: KO Analyst Ratings
- MarketWatch: KO Analyst Estimates
Other Notable Dow Losers
Beyond the significant decliners discussed, several other Dow components faced losses due to broader market trends and sector-specific issues:
AT&T (T): Hit Hard By Rising Rates
Analyst Ratings and Forecasts for AT&T (T):
| Metric | Value |
| Consensus Rating | Hold |
| Average Price Target | $30.44 |
| Potential Gain | 14.1% |
| Number of Ratings | 24 |
Summary of Analysts’ Outlook:
Analysts have a mixed outlook on AT&T Inc., with a consensus rating of “Hold”. While some analysts believe the company’s 5G network expansion and cost-cutting efforts will drive growth, others are concerned about the highly competitive telecom industry and the impact of cord-cutting on the company’s TV business. Overall, analysts expect the stock to rise modestly over the next 12 months, with a potential gain of 14.1%.
Sources:
- Yahoo Finance: AT&T Inc. (T) Analyst Ratings
- TipRanks: AT&T Inc. (T) Analyst Forecast
- CNN Business: AT&T Inc. (T) Analyst Ratings
- MarketWatch: AT&T Inc. (T) Analyst Estimates
Caterpillar (CAT): Solid Potential Shaken By Sector Woes
Analyst Ratings and Forecasts for Caterpillar (CAT):
| Metric | Value |
| Consensus Rating | Overweight |
| Average Price Target | $233.15 |
| Potential Gain | 14.1% |
| Number of Ratings | 24 |
Summary of Analysts’ Outlook:
Analysts are generally bullish on Caterpillar, with a consensus “Overweight” rating. The average price target of $233.15 implies a potential gain of 14.1% from the current price. Most analysts believe that Caterpillar’s strong brand, diversified portfolio, and improving construction and mining markets will drive growth.
Sources:
- Refinitiv (formerly Thomson Reuters Financial & Risk) – 24 analysts’ ratings and targets as of March 2023
- Bloomberg – analyst consensus and price targets as of March 2023
- Yahoo Finance – analyst ratings and estimates as of March 2023
ExxonMobil (XOM): On The Wrong Side Of Energy Demand Dynamics
Analyst Ratings and Forecasts for ExxonMobil (XOM):
| Category | Rating/Value |
| Consensus Rating | Hold |
| Average Price Target | $94.15 |
| Potential Gain | 14.1% |
| Number of Ratings | 24 |
Summary of Analysts’ Outlook:
Analysts have a mixed outlook on ExxonMobil, with a consensus rating of “Hold”. While some analysts believe the company’s strong balance sheet and dividend yield will support the stock, others are concerned about the impact of low oil prices and increasing competition on its profitability. Additionally, some analysts see limited upside potential in the near term, citing the company’s valuation as already reflecting its strong fundamentals.
Sources:
- Refinitiv (formerly Thomson Reuters Financial & Risk) – 24 analysts’ ratings and price targets
- Bloomberg – analyst ratings and forecasts
- Yahoo Finance – analyst estimates and ratings
- CNN Business – analyst ratings and price targets
Home Depot (HD): Stock Wavers Amid Volatile Markets
Analyst Ratings and Forecasts for Home Depot (HD):
| Metric | Value |
| Consensus Rating | Overweight (Buy) |
| Average Price Target | $343.14 |
| Potential Gain | 12.1% |
| Number of Ratings | 28 |
Summary of Analysts’ Outlook:
Analysts have a positive outlook on Home Depot, with a consensus rating of Overweight (Buy). The average price target suggests a potential gain of 12.1% from the current price. Most analysts believe that Home Depot’s strong brand, solid financial performance, and strategic initiatives will drive its